STERIS plc

STE 10-K · FY 2026
API behind this page

STE FY 2026 request

Playground key active
Request URL /api/financials?ticker=STE&year=2026&quarter=4&full_year_mode=true
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric FY 2026 FY 2025 YoY
Revenue 5,935.9 5,459.5 +8.7%
Show Product Lines breakouts
Capital equipment · AST 20 30.9 -35.3%
Capital equipment · Healthcare Segment 1,095.9 1,037.2 +5.7%
Capital equipment · Life Sciences 135.7 117.5 +15.5%
Consumables · Healthcare Segment 1,496.6 1,396 +7.2%
Consumables · Life Sciences 308.3 286.7 +7.5%
Product 3,060.1 2,871.6 +6.6%
Service 2,875.8 2,587.9 +11.1%
Service · AST 1,118.5 1,007.6 +11.0%
Service · Healthcare Segment 1,616 1,445.4 +11.8%
Service · Life Sciences 144.8 138.1 +4.9%
Show Business Segments breakouts
AST 1,138.5 1,038.6 +9.6%
AST · Operating Segments 1,138.5 1,038.6 +9.6%
Healthcare Segment 4,208.6 3,878.7 +8.5%
Healthcare Segment · Operating Segments 4,208.6 3,878.7 +8.5%
Life Sciences 588.8 542.3 +8.6%
Life Sciences · Operating Segments 588.8 542.3 +8.6%
Show Geography breakouts
IE 108.5 107.3 +1.1%
Other foreign locations 1,493.7 1,344.6 +11.1%
US 4,333.8 4,007.6 +8.1%
Cost of Revenue 3,309.4 3,056.8 +8.3%
Show Product Lines breakouts
Product 1,625.5 1,514.3 +7.3%
Service 1,683.9 1,542.5 +9.2%
Gross Profit 2,626.5 2,402.8 +9.3%
Selling, General & Administrative 1,407.7 1,334.3 +5.5%
Show Business Segments breakouts
AST · Operating Segments 57.7 52.5 +9.9%
Healthcare Segment · Operating Segments 652.3 610 +6.9%
Life Sciences · Operating Segments 65 59.8 +8.7%
Research & Development 112.9 107.6 +4.9%
Show Business Segments breakouts
AST · Operating Segments 3.3 3.8 -13.2%
Healthcare Segment · Operating Segments 97.5 93.1 +4.7%
Life Sciences · Operating Segments 10.3 9.4 +9.6%
Restructuring Costs 4.1 46 -91.1%
Operating Expenses 1,524.7 1,536.1 -0.7%
Operating Income 1,101.8 866.6 +27.1%
Interest Expense 60.7 86.3 -29.7%
Other Non-Operating Income (Expense) -9.8 -8.4 -16.7%
Gain Loss On Sale Of Business And Equity Investments Continuing Operations -3.5 7.4 -147.3%
Non-Operating Income (Expense) 54.4 70.4 -22.7%
Income Before Taxes 1,047.3 796.2 +31.5%
Income Tax Expense (Benefit) 262.2 184.7 +42.0%
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest 785.1 611.6 +28.4%
Net Income 785.1 616.1 +27.4%
Show Equity Components breakouts
Noncontrolling Interest 2.8 1.4 +100.0%
Retained Earnings 782.3 614.6 +27.3%
Net Income Loss Attributable To Noncontrolling Interest 2.8 1.4 +100.0%
Net Income 782.3 614.6 +27.3%
Income Loss From Continuing Operations Per Basic Share 7.97 6.19 +28.8%
EPS (Basic) 7.97 6.24 +27.7%
Income Loss From Continuing Operations Per Diluted Share 7.93 6.16 +28.7%
EPS (Diluted) 7.93 6.2 +27.9%
Common Stock Dividends Per Share Declared 2.46 2.23 +10.3%
Cost of Revenue (FY) — — —
Show Business Segments breakouts
AST · Operating Segments 552.8 516.7 +7.0%
Healthcare Segment · Operating Segments 2,422.5 2,204.1 +9.9%
Life Sciences · Operating Segments 262.7 243.7 +7.8%
Comprehensive Income 961.5 651 +47.7%
Other Comprehensive Income 179.2 36.3 +393.7%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 0.6 -0.1 +700.0%
Accumulated Translation Adjustment -179.7 -36.2 -396.4%
Wtd Avg Shares (Basic) 98.2 98.6 -0.4%
Wtd Avg Shares (Diluted) 98.7 99.1 -0.4%

Balance Sheet

Balance Sheet
Metric FY 2026 FY 2025 YoY
Current Assets
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 439.6 171.7 +156.0%
Accounts Receivable 1,092.8 1,044 +4.7%
Inventory 631.8 581.3 +8.7%
Other Prepaid Expense Current 230.4 203.8 +13.1%
Total Current Assets 2,394.6 2,000.8 +19.7%
Non-Current Assets
Property, Plant & Equipment 2,161.2 1,956.5 +10.5%
Show Geography breakouts
IE 88.1 74.9 +17.6%
Other Foreign Entities [Member] 978.7 872.9 +12.1%
US 1,094.4 1,008.7 +8.5%
Operating Lease Right-of-Use Assets 155.2 156.4 -0.8%
Show Business Acquisition breakouts
Series Of Individually Immaterial Business Acquisitions 1 4.6 -78.3%
Goodwill 4,194.8 4,095.7 +2.4%
Show Business Acquisition breakouts
Series Of Individually Immaterial Business Acquisitions 8.8 10.6 -17.0%
Show Reporting Unit breakouts
AST 1,482.3 1,415.4 +4.7%
Health Care 2,539 2,509.3 +1.2%
Life Sciences 173.5 170.9 +1.5%
Other Non-Current Assets 211.4 83 +154.7%
Total Assets 10,737.2 10,146.8 +5.8%
Show Business Segments breakouts
AST · Segment Continuing Operations 3,590.4 3,340.4 +7.5%
Healthcare and Life Sciences · Segment Continuing Operations 7,146.8 6,806.4 +5.0%
Show Statement Operating Activities Segment breakouts
Segment Continuing Operations 10,737.2 10,146.8 +5.8%
Other Assets
Intangible Assets Net Excluding Goodwill 1,620 1,854.4 -12.6%
Current Liabilities
Accounts Payable 338.8 280.8 +20.7%
Accrued Income Taxes Current 28.6 21.5 +33.0%
Employee Related Liabilities Current 221.1 192.7 +14.7%
Operating Lease Liability Current 35.8 34.2 +4.7%
Short Term Borrowings 118.9 125 -4.9%
Accrued Liabilities 401.9 368.1 +9.2%
Total Current Liabilities 1,145 1,022.2 +12.0%
Non-Current Liabilities
Long-Term Debt 1,812.8 1,918.7 -5.5%
Deferred Income Taxes And Other Tax Liabilities Noncurrent 390.7 403.7 -3.2%
Operating Lease Liabilities 119.6 124.6 -4.0%
Other Non-Current Liabilities 71.7 61.9 +15.8%
Total Liabilities 3,540 3,531.1 +0.3%
Long-Term Debt 1,812.8 1,918.7 -5.5%
Show Long-Term Debt Type breakouts
Senior Notes 557.8 674.2 -17.3%
STE 1.86% due 2027 Senior Notes 68.9 65 +6.0%
STE 2.04% due 2029 Senior Notes 23 21.7 +6.0%
STE 2.30% due 2032 Senior Notes 21.8 20.6 +5.8%
STE 3.04% due 2029 Senior Notes 59.5 58.2 +2.2%
STE 3.17% due 2032 Senior Notes 39.7 38.8 +2.3%
STE 3.55% due 2027 Senior Notes 125 125 0.0%
STE 3.70% due 2030 Senior Notes 100 100 0.0%
STE 3.93% due 2027 Senior Notes 50 50 0.0%
STE 4.03% due 2029 Senior Notes 45 45 0.0%
STE 4.05% due 2027 Senior Notes 25 25 0.0%
Accrued Income Taxes Noncurrent 0.3 1.9 -84.2%
Other Liabilities
Commitments And Contingencies (Q) — — —
Show Purchase Commitment Excluding Longterm Commitment breakouts
Commercial commitments [Member] 161.3 127.4 +26.6%
Long term Construction Contracts [Member] [Member] 71.5 — —
Minority Interest 13.6 12.4 +9.7%
Stockholders' Equity
Common Stock 4,280.9 4,420.4 -3.2%
Retained Earnings 3,015.9 2,475.3 +21.8%
Accumulated Other Comprehensive Income -113.1 -292.3 +61.3%
Total Stockholders' Equity 7,183.6 6,603.4 +8.8%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7,197.2 6,615.8 +8.8%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -113.1 -292.3 +61.3%
Common Stock 4,280.9 4,420.4 -3.2%
Noncontrolling Interest 13.6 12.4 +9.7%
Retained Earnings 3,015.9 2,475.3 +21.8%
Total Liabilities & Equity 10,737.2 10,146.8 +5.8%

Cash Flow Statement

Cash Flow Statement
Metric FY 2026 FY 2025 YoY
Operating Activities
Depreciation & Amortization 486.5 476.2 +2.2%
Show Business Segments breakouts
AST · Segment Continuing Operations 156.8 142 +10.4%
Healthcare and Life Sciences · Segment Continuing Operations 329.8 334.2 -1.3%
Show Statement Operating Activities Segment breakouts
Segment Continuing Operations 486.5 476.2 +2.2%
Deferred Income Taxes -16.9 -76.5 +77.9%
Stock-Based Compensation 61.7 57.4 +7.5%
Gain Loss On Sale Of Property Plant Equipment 3.6 5.7 -36.8%
Gain Loss On Disposition Of Business And Equity Investments Net -0.3 6.4 -104.7%
Other Non-Cash Items -5.6 -3.7 -51.4%
Change in Accounts Receivable -25.1 -28.8 +12.8%
Change in Inventory -24 73.1 -132.8%
Change in Prepaid & Other Assets -22.7 -50.3 +54.9%
Change in Accounts Payable 51.1 33.6 +52.1%
Increase Decrease In Accrued Liabilities 47.8 38.9 +22.9%
Net Cash from Operations 1,341.4 1,148.1 +16.8%
Investing Activities
Capital Expenditures -369 -370.1 +0.3%
Proceeds From Sale Of Property Plant And Equipment 10.5 9.2 +14.1%
Proceeds From Divestiture Of Businesses (FY) — — —
Show Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations breakouts
CECS 41.9 — —
Payments To Acquire Investments -134 -10.8 -1140.7%
Payments To Acquire Businesses Net Of Cash Acquired -20.1 -54.1 +62.8%
Show Asset Acquisition breakouts
BD Acquisition -539.8 — —
Show Business Acquisition breakouts
Other FY 25 Acquisition -23.4 — —
Net Cash from Investing -512.5 388.8 -231.8%
Financing Activities
Payments For Repurchase Of Private Placement -125 -80 -56.2%
Proceeds From Repayments Of Lines Of Credit 3 -446.3 +100.7%
Payments Of Merger Related Costs Financing Activities -0.4 -0.4 0.0%
Share Repurchases -235.5 -211.3 -11.5%
Payments Of Dividends Common Stock -241.8 -219.9 -10.0%
Payments To Minority Shareholders -1.4 -2.1 +33.3%
Proceeds From Payments For Other Financing Activities 32.9 25.5 +29.0%
Net Cash from Financing -568.2 -1,572.4 +63.9%
Tax Withholding for Share Compensation 12.5 11.3 +10.6%
Supplemental
Income Taxes Paid 289 273.6 +5.6%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 7.2 0.2 +3500.0%
Net Change in Cash 267.9 -35.3 +858.9%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key